Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Clinical trial NCT04380740 · RECRUITING

Trial details

NCT number: NCT04380740
Sponsor: Boston Children's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Vs Host Disease

Start date: 2022-03-30
Primary completion: 2027-05-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.